GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MAKO Surgical Corporation (FRA:4M6) » Definitions » Piotroski F-Score

MAKO Surgical (FRA:4M6) Piotroski F-Score : 0 (As of Jun. 25, 2024)


View and export this data going back to . Start your Free Trial

What is MAKO Surgical Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

MAKO Surgical has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for MAKO Surgical's Piotroski F-Score or its related term are showing as below:


MAKO Surgical Piotroski F-Score Historical Data

The historical data trend for MAKO Surgical's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MAKO Surgical Piotroski F-Score Chart

MAKO Surgical Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 4.00 4.00 4.00 4.00

MAKO Surgical Quarterly Data
Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 4.00 4.00 3.00 3.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep13) TTM:Last Year (Sep12) TTM:
Net Income was -4.368 + -7.427 + -14.954 + -15.899 = €-42.65 Mil.
Cash Flow from Operations was 1.332 + -1.75 + -3.757 + -5.073 = €-9.25 Mil.
Revenue was 23.034 + 19.153 + 21.395 + 17.026 = €80.61 Mil.
Gross Profit was 15.433 + 14.104 + 12.723 + 12.213 = €54.47 Mil.
Average Total Assets from the begining of this year (Sep12)
to the end of this year (Sep13) was
(88.797 + 127.179 + 121.232 + 109.545 + 102.187) / 5 = €109.788 Mil.
Total Assets at the begining of this year (Sep12) was €88.80 Mil.
Long-Term Debt & Capital Lease Obligation was €0.00 Mil.
Total Current Assets was €73.67 Mil.
Total Current Liabilities was €29.04 Mil.
Net Income was -4.244 + -8.88 + -6.802 + -5.086 = €-25.01 Mil.

Revenue was 24.995 + 14.867 + 18.869 + 22.641 = €81.37 Mil.
Gross Profit was 17.034 + 10.714 + 13.796 + 13.35 = €54.89 Mil.
Average Total Assets from the begining of last year (Sep11)
to the end of last year (Sep12) was
(89.255 + 97.106 + 87.286 + 96.079 + 88.797) / 5 = €91.7046 Mil.
Total Assets at the begining of last year (Sep11) was €89.26 Mil.
Long-Term Debt & Capital Lease Obligation was €0.00 Mil.
Total Current Assets was €65.40 Mil.
Total Current Liabilities was €15.52 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

MAKO Surgical's current Net Income (TTM) was -42.65. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

MAKO Surgical's current Cash Flow from Operations (TTM) was -9.25. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep12)
=-42.648/88.797
=-0.4802865

ROA (Last Year)=Net Income/Total Assets (Sep11)
=-25.012/89.255
=-0.2802308

MAKO Surgical's return on assets of this year was -0.4802865. MAKO Surgical's return on assets of last year was -0.2802308. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

MAKO Surgical's current Net Income (TTM) was -42.65. MAKO Surgical's current Cash Flow from Operations (TTM) was -9.25. ==> -9.25 > -42.65 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep13)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep12 to Sep13
=0/109.788
=0

Gearing (Last Year: Sep12)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep11 to Sep12
=0/91.7046
=0

MAKO Surgical's gearing of this year was 0. MAKO Surgical's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep13)=Total Current Assets/Total Current Liabilities
=73.671/29.04
=2.53688017

Current Ratio (Last Year: Sep12)=Total Current Assets/Total Current Liabilities
=65.402/15.521
=4.21377489

MAKO Surgical's current ratio of this year was 2.53688017. MAKO Surgical's current ratio of last year was 4.21377489. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

MAKO Surgical's number of shares in issue this year was 47.036. MAKO Surgical's number of shares in issue last year was 42.306. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=54.473/80.608
=0.6757766

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=54.894/81.372
=0.67460552

MAKO Surgical's gross margin of this year was 0.6757766. MAKO Surgical's gross margin of last year was 0.67460552. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep12)
=80.608/88.797
=0.90777842

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep11)
=81.372/89.255
=0.91168002

MAKO Surgical's asset turnover of this year was 0.90777842. MAKO Surgical's asset turnover of last year was 0.91168002. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+0+1+0
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

MAKO Surgical has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

MAKO Surgical  (FRA:4M6) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


MAKO Surgical Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of MAKO Surgical's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


MAKO Surgical (FRA:4M6) Business Description

Traded in Other Exchanges
N/A
Address
MAKO Surgical Corporation was incorporated in Delaware in November 2004. The Company is a medical device company that markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures. It offers MAKOplasty, an innovative, restorative surgical solution that enables orthopedic surgeons to consistently, reproducibly and precisely treat patient specific, osteoarthritic disease. The Company currently offers MAKOplasty Partial Knee Arthroplasty, or MAKOplasty PKA, and MAKOplasty Total Hip Arthroplasty, or MAKOplasty THA. MAKOplasty PKA, which requires extraction and replacement of the entire joint, enables resurfacing of one or two specific diseased compartments of the joint, preserving significantly more soft tissue and healthy bone of the knee. MAKOplasty procedures are enabled through its proprietary technology consisting of the components which includes its RIO system, its MAKOplasty applications, and its RESTORIS family of implant systems. The centerpiece of MAKOplasty is the RIO system, its proprietary robotic arm, interactive, orthopedic system, that provides both pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal and accurate implant insertion and alignment. The RIO system consists of two elements: a tactile robotic arm utilizing an integrated bone cutting instrument and a patient specific visualization component. The RIO system, version 2.0 of its Tactile Guidance System, or TGS, represents an important expansion from its first generation TGS, enabling and expanding the MAKOplasty PKA application to multicompartmental resurfacing procedures, allowing orthopedic surgeons to treat degenerative knee osteoarthritis from early-stage, unicompartmental degeneration through mid-stage, multicompartmental degeneration with a modular knee implant system, as well as enabling the MAKOplasty THA application. The Company's MAKOplasty PKA application enables surgeons to isolate and resurface just one or two specific diseased compartments of the joint through a minimally invasive incision, preserving significantly more soft tissue and healthy bone of the knee. The MAKOplasty knee resurfacing procedure is performed by the surgeon using the surgical planning and execution software integrated into its patient specific visualization system. The Company's MAKOplasty THA application utilizes the RIO system's tactile, visual and auditory feedback to assist the surgeon in preparing the acetabulum (hip socket) for optimal placement of the acetabular cup implant. The MAKOplasty THA application allows the surgeon to preoperatively plan the placement of the hip implants on a three dimensional image of a pre-operative CT scan. Its RESTORIS family of knee implants is designed to enable minimally invasive restoration of one or two of the diseased compartments of the knee joint. Its RESTORIS family of knee implants for use in si

MAKO Surgical (FRA:4M6) Headlines

No Headlines